.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Spotlight

In-person and virtual events just for HCPs

SpecialtySee All >

Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer

Advertise
About OncLive
Editorial Board
MJH Life Sciences brands
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information

2 Clarke Drive
Suite 100
Cranbury, NJ 08512

Marcia Brose, MD, PhD

EP. 1: Approval of Lenvatinib: More Options

March 4th 2015

EP. 2: Who Are the Best Candidates for TKIs?

March 4th 2015

EP. 3: Interpreting Whole Body Scans

March 4th 2015

EP. 4: Genetic Testing: What Role Do Mutations Play?

March 4th 2015

EP. 5: Treatments After Progression in DTC

March 4th 2015

EP. 6: When to Refer a Patient to a Medical Oncologist

March 4th 2015

EP. 7: Monitoring During Active Surveillance and Treatment

March 4th 2015

EP. 8: Key Findings From DECISION and SELECT Trials

March 4th 2015

EP. 9: Current and Future Targets in Thyroid Cancer

March 4th 2015

EP. 10: More Personalized Therapy Needed to Improve Survival

March 4th 2015

EP. 11: Medullary Thyroid Cancer: What is Available?

March 4th 2015